Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 30;1(1):100011.
doi: 10.1016/j.jscai.2021.100011. eCollection 2022 Jan-Feb.

Sex-Specific Outcomes After Coronary Intravascular Lithotripsy: A Patient-Level Analysis of the Disrupt CAD Studies

Yasin Hussain  1 , Kathleen E Kearney  2 , J Dawn Abbott  3 , Dean J Kereiakes  4 , Carlo Di Mario  5 , Shigeru Saito  6 , Ecaterina Cristea  1 , Robert F Riley  4 , Jean Fajadet  7 , Richard A Shlofmitz  8 , Ziad A Ali  8   9 , Andrew J Klein  10 , Matthew J Price  11 , Jonathan M Hill  12 , Gregg W Stone  13 , Alexandra J Lansky  1   14
Affiliations

Sex-Specific Outcomes After Coronary Intravascular Lithotripsy: A Patient-Level Analysis of the Disrupt CAD Studies

Yasin Hussain et al. J Soc Cardiovasc Angiogr Interv. .

Erratum in

  • Correction.
    [No authors listed] [No authors listed] J Soc Cardiovasc Angiogr Interv. 2025 Aug 9;4(10Part A):103930. doi: 10.1016/j.jscai.2025.103930. eCollection 2025 Oct. J Soc Cardiovasc Angiogr Interv. 2025. PMID: 41268087 Free PMC article.

Abstract

Background: Coronary artery calcification increases the procedural complexity of percutaneous coronary intervention and is associated with worse outcomes, especially in women. Intravascular lithotripsy (IVL) has been demonstrated to be safe and effective for vessel preparation in severely calcified stenotic lesions before stent implantation. Sex-based outcomes of IVL-facilitated stenting have not been defined.

Methods: We performed a patient-level pooled analysis of the 4 prospective, single-arm Disrupt CAD studies that evaluated the safety and efficacy of IVL-facilitated stenting. Patient baseline and procedural characteristics and clinical outcomes were examined based on sex. The primary safety end point was 30-day major adverse cardiovascular events, defined as the composite of cardiac death, myocardial infarction, or target vessel revascularization. The primary efficacy end point was procedural success, defined as stent delivery with residual in-stent stenosis ≤30% without in-hospital major adverse cardiovascular events.

Results: A total of 628 patients were included, of which 144 (22.9%) were women. Women were older (P < .001) and more likely to have hyperlipidemia (P = .03), renal insufficiency (P = .05), and prior myocardial infarction (P = .05). Women had smaller mean reference vessel diameter (2.7 ​ ± ​0.4 ​mm vs 3.0 ​ ± ​0.5 ​mm, P < .001), shorter lesion length (22.4 ​ ± ​10.3 ​mm vs 25.0 ​ ± ​11.7 ​mm, P = .01), and less side branch involvement (22.9% vs 32.4%, P = .03). Severe coronary calcification defined by angiography, stent delivery success, lesion predilatation, post-IVL dilatation, and poststent dilatation was similar between groups. There were no significant differences between women and men in the primary safety end point (8.3% vs 7.1%, P = .61; adjusted odds ratio 1.66; 95% confidence interval 0.78, 3.34; P = .17) or the primary efficacy end point (91.7% vs 92.6%, P = .72; adjusted odds ratio 0.58; 95% confidence interval 0.29, 1.24; P = .15). Post-IVL serious angiographic complications (flow-limiting dissection, perforation, abrupt closure, slow flow, no reflow) were similar for women and men (1.6% vs 2.3%, P = .75).

Conclusions: Despite more comorbidities and smaller vessel size, IVL-facilitated stenting of severely calcified lesions achieves similar safety and efficacy in women and men.

Keywords: Calcium; Coronary artery disease; Intravascular lithotripsy; Percutaneous coronary intervention.; Sex.

PubMed Disclaimer

Figures

None
Graphical abstract
None
See this image and copyright information in PMC

References

    1. Lawton J.S., Tamis-Holland J.E., Bangalore S., et al. ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;79:197–215. - PubMed
    1. Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J. 2014;35:2541–2619. - PubMed
    1. Madhavan M.V., Tarigopula M., Mintz G.S., Maehara A., Stone G.W., Généreux P. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol. 2014;63:1703–1714. - PubMed
    1. Huisman J., van der Heijden L.C., Kok M.M., et al. Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: a patient-level pooled analysis from TWENTE and Dutch PEERS (TWENTE II) Am Heart J. 2016;175:121–129. - PubMed
    1. Généreux P., Madhavan M.V., Mintz G.S., et al. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trials. J Am Coll Cardiol. 2014;63:1845–1854. - PubMed

LinkOut - more resources